GlassScriptPhysician profile
Ashley Wach
NPI 1497057384
$1,009.24
in general payments reported to CMS, 2019-2025
16 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $103 · 2023: $387 · 2024: $305 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $156.53 | 2021-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $120.94 | 2021-2023 | Farxiga |
| Glaxosmithkline, LLC. | $104.20 | 2021-2025 | Arexvy, Trelegy Ellipta, Bexsero |
| Lilly USA, LLC | $79.00 | 2021-2024 | Jardiance, Trulicity, Mounjaro |
| Exact Sciences Corporation | $68.77 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $65.52 | 2023-2025 | |
| Amgen INC. | $58.88 | 2023-2024 | Repatha, Otezla |
| Corium, LLC | $51.50 | 2023 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $51.23 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $50.84 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.89 | 2024 | Jardiance |
| Pfizer INC. | $48.75 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $43.96 | 2021-2022 | |
| Sanofi Pasteur INC. | $21.80 | 2022 | |
| Hologic Sales and Service, LLC | $19.90 | 2023 | Thinprep 2000 Processor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.53 | 2023 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Wach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.